The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services.

by Michael W Traeger, Alisa E Pedrana, Daniela K van Santen, Joseph S Doyle, Jessica Howell, Alexander J Thompson, Carol El-Hayek, Jason Asselin, Victoria Polkinghorne, Dean Membrey, Fran Bramwell, Allison Carter, Rebecca Guy, Mark A Stoové, Margaret E Hellard, EC Victoria Partnership and the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Blood-borne Viruses and Sexually Transmitted Infections (ACCESS)
Published 2020-01-01